These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11716172)

  • 1. L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro.
    Muijsers RB; ten Hacken NH; Van Ark I; Folkerts G; Nijkamp FP; Postma DS
    Eur Respir J; 2001 Oct; 18(4):667-71. PubMed ID: 11716172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
    Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
    Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis.
    Hecker M; Nematollahi H; Hey C; Busse R; Racké K
    FEBS Lett; 1995 Feb; 359(2-3):251-4. PubMed ID: 7532597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.
    Tenu JP; Lepoivre M; Moali C; Brollo M; Mansuy D; Boucher JL
    Nitric Oxide; 1999 Dec; 3(6):427-38. PubMed ID: 10637120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages.
    Hammermann R; Stichnote C; Closs EI; Nawrath H; Racké K
    Br J Pharmacol; 2001 Jun; 133(3):379-86. PubMed ID: 11375254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase modulates nitric oxide production in activated macrophages.
    Chang CI; Liao JC; Kuo L
    Am J Physiol; 1998 Jan; 274(1):H342-8. PubMed ID: 9458885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition by dantrolene of L-arginine transport and nitric oxide synthase in rat alveolar macrophages.
    Chou TC; Li CY; Wu CC; Yen MH; Ding YA
    Anesth Analg; 1998 May; 86(5):1065-9. PubMed ID: 9585299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase.
    Hrabák A; Bajor T; Temesi A; Mészáros G
    FEBS Lett; 1996 Jul; 390(2):203-6. PubMed ID: 8706860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo.
    Meyer J; Richter N; Hecker M
    Anal Biochem; 1997 Apr; 247(1):11-6. PubMed ID: 9126364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis.
    Gobert AP; Daulouede S; Lepoivre M; Boucher JL; Bouteille B; Buguet A; Cespuglio R; Veyret B; Vincendeau P
    Infect Immun; 2000 Aug; 68(8):4653-7. PubMed ID: 10899869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
    Iniesta V; Gómez-Nieto LC; Corraliza I
    J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High glucose augments arginase activity and nitric oxide production in the renal cortex.
    Ishii N; Ikenaga H; Carmines PK; Aoki Y; Ogawa Z; Saruta T; Suga T
    Metabolism; 2004 Jul; 53(7):868-74. PubMed ID: 15254879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity.
    Hey C; Wessler I; Racké K
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):651-9. PubMed ID: 7545789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis.
    Hammermann R; Hirschmann J; Hey C; Mössner J; Folkerts G; Nijkamp FP; Wessler I; Racké K
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):155-62. PubMed ID: 10423396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells.
    Topal G; Brunet A; Walch L; Boucher JL; David-Dufilho M
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1368-74. PubMed ID: 16801455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters.
    Closs EI; Scheld JS; Sharafi M; Förstermann U
    Mol Pharmacol; 2000 Jan; 57(1):68-74. PubMed ID: 10617680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.
    Bianchi M; Ulrich P; Bloom O; Meistrell M; Zimmerman GA; Schmidtmayerova H; Bukrinsky M; Donnelley T; Bucala R; Sherry B
    Mol Med; 1995 Mar; 1(3):254-66. PubMed ID: 8529104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.